Inhibition of Ca2+/calmodulin-dependent protein kinase II, RAS-GTPase and 20-hydroxyeicosatetraenoic acid attenuates the development of diabetes-induced vascular dysfunction in the rat carotid artery

被引:29
|
作者
Benter, IF
Yousif, MHM
Canatan, H
Akhtar, S
机构
[1] Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Safat 13110, Kuwait
[2] Cardiff Univ, Welsh Sch Pharm, Ctr Genome Based Therapeut, Cardiff CF10 3XF, S Glam, Wales
关键词
diabetes; carotid artery; cytochrome P450; 20-HETE;
D O I
10.1016/j.phrs.2005.04.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Diabetes causes accelerated vascular dysfunction through mechanisms that are poorly understood. This study examined the role of Ca2+/calmodulin-dependent protein kinase II (CaMKII), Ras-GTPase and 20-hydroxyeicosatetraenoic acid (20-HETE) in the development of abnormal reactivity to vasoactive agents in the carotid artery of diabetic rats. The vasoconstrictor response induced by endothelin-1 (ET-I) was significantly increased, whereas vasodilator response to carbachol was significantly reduced in the carotid artery segments of the STZ-diabetic rats. In contrast, the vasoconstrictor response to depolarization of the carotid arterial rings with 50 mM KCl was similar in control and diabetic animals. Chronic intraperitoneal administration of KN-93 (5 mg/kg/alt diem), an inhibitor of CaMKII, FPTIII (1.5 mg/kg/aIt diem), an inhibitor of Ras-GTPase, and inhibitors of 20-HETE formation 1-aminobenzotriazole (ABT, 50 mg/kg/alt diem) and N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine (HET0016, 2.5 mg/kg/day), produced significant normalization of the altered agonist-induced vasoconstrictor and vasodilator responses without affecting blood glucose levels. All the inhibitors were administered for 4 weeks starting from the day 1 of diabetes induction. Inhibition of CaMKII, Ras-GTPase or 20-HETE formation did not affect the agonist-induced vasoconstrictor and vasodilator responses in the non-diabetic control animals. These data indicate that chronic blockade of CaMKII, Ras-GTPase or the production of 20-HETE normalizes the altered vascular reactivity to ET-1 and carbachol in the carotid artery of STZ-induced diabetic rats. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:252 / 257
页数:6
相关论文
共 50 条
  • [21] Inhibition of Ca2+/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in Rats
    Shirahama, Masafumi
    Ushio, Soichiro
    Egashira, Nobuaki
    Yamamoto, Shota
    Sada, Hikaru
    Masuguchi, Ken
    Kawashiri, Takehiro
    Oishi, Ryozo
    MOLECULAR PAIN, 2012, 8
  • [22] Regulation of Ca2+/calmodulin-dependent protein kinase II phosphorylation by the RAS-related protein, Ral-A
    Roufogalis, BD
    Wang, KL
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R649 - R649
  • [23] Ca2+-induced loss of Ca2+/calmodulin-dependent protein kinase II activity in permeabilized rat islets of Langerhans
    Harris, TE
    Persaud, SJ
    Jones, PM
    DIABETOLOGIA, 1998, 41 : A142 - A142
  • [24] Chronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure
    Liu, Yixi
    Shao, Qun
    Cheng, Heng-Jie
    Li, Tiankai
    Zhang, Xiaowei
    Callahan, Michael F.
    Herrington, David
    Kitzman, Dalane
    Zhao, David
    Cheng, Che-Ping
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2021, 377 (03): : 316 - 325
  • [25] Reversal of chronic inflammatory pain by acute inhibition of Ca2+/calmodulin-dependent protein kinase II
    Luo, Fang
    Yang, Cheng
    Chen, Yan
    Shukla, Pradeep
    Tang, Lei
    Wang, Lili X.
    Wang, Zaijie Jim
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 325 (01): : 267 - 275
  • [26] Curcumin Attenuates Opioid Tolerance and Dependence by Inhibiting Ca2+/Calmodulin-Dependent Protein Kinase II α Activity
    Hu, Xiaoyu
    Huang, Fang
    Szymusiak, Magdalena
    Liu, Ying
    Wang, Zaijie Jim
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2015, 352 (03): : 420 - 428
  • [27] Identification of the isoforms of Ca2+/calmodulin-dependent protein kinase II in rat astrocytes and their subcellular localization
    Takeuchi, Y
    Yamamoto, H
    Fukunaga, K
    Miyakawa, T
    Miyamoto, E
    JOURNAL OF NEUROCHEMISTRY, 2000, 74 (06) : 2557 - 2567
  • [28] Search for mutations of the Ca2+/calmodulin-dependent protein kinase II δ in patients with type 2 diabetes mellitus
    Voigt, A
    Rochlitz, H
    Schatz, H
    Pfeiffer, AFH
    DIABETOLOGIA, 2001, 44 : A88 - A88
  • [29] Ca2+-induced loss of Ca2+/calmodulin-dependent protein kinase II activity in pancreatic β-cells
    Jones, PM
    Persaud, SJ
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1998, 274 (04): : E708 - E715
  • [30] Effects of Ca2+/calmodulin-dependent protein kinase II inhibitors on Ca2+ signaling in bovine vascular endothelial cells.
    Aromolaran, AAS
    Blatter, LA
    BIOPHYSICAL JOURNAL, 2003, 84 (02) : 392A - 392A